Navigating Dose Range Finding Studies
In the crucial early stages of drug development, dose range finding (DRF) studies play a pivotal role in determining a drug's safety and efficacy potential. By exploring different dose levels, experts not only establish the minimum effective dose and maximum tolerated dose, but also provide invaluable data for designing targeted subsequent studies.
Dose range finding studies act as cartographers, meticulously charting the safe and effective dosage range for a drug candidate.
- What's the minimum effective dose (MED) needed to produce the desired therapeutic effect?
- What's the maximum tolerated dose (MTD) before adverse effects become unacceptable?
- How does the drug's efficacy and safety profile change across different dose levels?
With the right strategic partner by your side, your journey through the preclinical toxicology labyrinth will be a smooth one led with integrity, experience, and an unwavering commitment to quality and success.
Dose Range Finding Study Purpose
A DRF study has two main purposes:
- Identify the safe and effective dose range: It aims to find the minimum effective dose (MED) needed to produce the desired effect and the maximum tolerated dose (MTD) before side effects become unacceptable. This knowledge guides the design of further studies and sets safe dosing parameters for potential future drugs.
- Gather data for targeted testing: DRF studies collect valuable information about how the drug affects the body at different doses. This data helps researchers design efficient and focused subsequent studies, minimizing unnecessary animal testing, and optimizing resource allocation.
No matter how difficult the question or rare the compound, Charles River is always on the top of their game. This company continues to develop new skills to stay competitive and their scientific approaches are cutting edge. I know I can always count on them for their support, which is why I continue to come back time and time again.”
Associate Director of Toxicology, Pharmaceutical Company
Dispelling the “Cookie Cutter” Fallacy of Small Molecule IND
View this webinar to discover how to adapt your approach to your IND program’s unique challenges to gain a competitive edge.
Watch the Webinar
Dose Range Finding Examinations and Services
Study Dosing Routes
The choice of dosing route depends on various factors, including the physiochemical properties of the compound, its intended route of administration in humans, and the specific objectives of the study. Using multiple dosing routes, when relevant, can provide a more comprehensive assessment of the compound’s toxicity profile. Our expert toxicologists can help guide you to the most appropriate route(s) of dosing for your drug.
- Oral
- Intravenous
- Intraperitoneal
- Subcutaneous
- Dermal
- Inhalation
Dose Range Finding Study Evaluations
Various types of evaluations are performed to assess the toxicity profile of a compound. These evaluations help characterize the potential adverse effects associated with different dose levels. Some common types of evaluations are listed here. Our scientists can help craft a tailored evaluation profile best suited to your test article.
- Clinical Observations
- Body Weight and Food Consumption
- Clinical Pathology
- Organ Weight and Gross Pathology
- Histopathology
- Toxicokinetics
- Other Specialized Assessments such as Ocular Toxicology, Developmental and Reproductive Toxicology, and more.
Get Our SEND E-Guide
SEND regulations can be a challenge to navigate on your own. Our E-Guide can help.
Access the E-Guide
The Difference Between Non-GLP and GLP DRF Studies
Non-GLP and GLP dose range finding studies both explore safe and effective doses for drugs, but with different levels of detail and regulatory importance. Non-GLP studies use simpler designs with fewer animals to get a rough idea of the dose range that might work. This information is useful for early decision-making but not directly usable for regulatory approval. GLP DRF studies follow strict protocols and use larger animal groups to create a precise map of the safe and effective dose range. This high-quality data is needed for regulatory submissions and ultimately paves the way for further drug development. Choosing between non-GLP and GLP depends on your research stage.
Frequently Asked Questions (FAQs) About Dose Range Finding Studies
-
When are dose range finding studies conducted?
DRF studies typically take place early in the preclinical safety assessment stage of drug development, before larger and more comprehensive studies like repeat-dose toxicity and genotoxicity assessments.
-
How can DRF studies be used to optimize the overall preclinical safety assessment program?
DRF studies act like early GPS for preclinical safety. They pinpoint the safe dose range, letting researchers focus later tests on that zone. This saves time, reduces animal testing, and ensures studies target the right doses, leading to a smoother, more efficient safety assessment journey.